VAERS Explorer
Back to explore

Report #2827736

Received Feb 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
IN
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPAHEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALSUNKJ4K4X—

Symptoms (1)

Underdose

Symptom narrative

A 45 years old female patient received a pediatric dose of Havrix.; underdose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 45-year-old female patient who received HAV (Havrix pediatric) (batch number J4K4X, expiry date 28-DEC-2026) for prophylaxis. On an unknown date, the patient received Havrix pediatric. On an unknown date, an unknown time after receiving Havrix pediatric, the patient experienced adult use of a child product (Verbatim: A 45 years old female patient received a pediatric dose of Havrix.) and underdose (Verbatim: underdose). The outcome of the adult use of a child product and underdose were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-FEB-2025 The health care professional reported that they administered a pediatric dose of Havrix to a 45 years old female patient, which led to adult use of a child product and underdose. The reporter was ask what is the protocol to follow.